Science Explorer Interactive view Map
Company · New Haven · United States

Melinta Therapeutics (United States)

melinta.comROR OpenAlex
Research works
112
▲ 59% vs 2013–17
Citations
3k
26.8 per fractional work
Top-10% rate
16.0%
record average 16.5%
Open access
51%
world 28%

Not ranked overall: Melinta Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.41× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.54× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 8.08× its world share, 2 worksImmunology and Micro…Neuroscience: 0.07× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 7.40× its world share, 1 worksPharmacology, Toxico…Engineering: 0.22× its world share, 1 worksEngineeringEnvironmental Science: 0.01× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.03× its world share, 0 worksMaterials ScienceHealth Professions: 2.37× its world share, 1 worksHealth ProfessionsMedicine: 2.67× its world share, 11 worksMedicineNursing: 0.20× its world share, 0 worksNursingBusiness, Management and Accounting: 0.28× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 2.15× its world share, 1 worksEconomics, Econometr…Psychology: 0.60× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.1×. Every wedge is a field page.

Which keywords describe research at Melinta Therapeutics (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Therapy, Epidemiology, Tumor Microenvironment, Antimicrobial Resistance, PET Imaging, Antibiotic Resistance, Fibroblast Activation Protein and Immunosuppression.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 12 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 12 words, with their numbers
  1. Epidemiology4▲ 4.1×16 topics
  2. Cancer Therapy3▲ 23×8 topics
  3. Antimicrobial Resistance2▲ 58×4 topics
  4. Tumor Microenvironment2▲ 27×3 topics
  5. PET Imaging2▲ 59×3 topics
  6. Antibiotic Resistance2▲ 25×5 topics
  7. Fibroblast Activation Protein2▲ 195×1 topic
  8. Immunosuppression2▲ 95×1 topic
  9. Antibiotic Pharmacokinetics2▲ 262×1 topic
  10. Critically Ill Patients2▲ 262×1 topic
  11. Public Health1▲ 4.0×5 topics
  12. Healthcare-Associated Infections1▲ 43×4 topics

Which research topics does Melinta Therapeutics (United States) publish most on?

By volume in 2022–2025: Peptidase Inhibition and Analysis, Antibiotics Pharmacokinetics and Efficacy, Antibiotic Resistance in Bacteria and Antibiotic Use and Resistance.

Peptidase Inhibition and…2Peptidase Inhibition and Analysis: 2 fractional worksAntibiotics Pharmacokine…2Antibiotics Pharmacokinetics and Efficacy: 2 fractional worksAntibiotic Resistance in Bacteria: 1 fractional worksAntibiotic Use and Resistance: 1 fractional worksAntifungal resistance and susceptibility: 1 fractional worksUbiquitin and proteasome…1Ubiquitin and proteasome pathways: 1 fractional worksPharmaceutical Economics and Policy: 0 fractional worksAntimicrobial Resistance in Staphylococcus: 0 fractional worksCancer Mechanisms and Therapy: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional works
OncologyPharmacologyMolecular MedicineApplied Microbiology and Biotechnology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Peptidase Inhibition and Analysis Oncology 2 works
  2. 2 Antibiotics Pharmacokinetics and Efficacy Pharmacology 2 works
  3. 3 Antibiotic Resistance in Bacteria Molecular Medicine 1 works
  4. 4 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 1 works
  5. 5 Antifungal resistance and susceptibility Infectious Diseases 1 works
  6. 6 Ubiquitin and proteasome pathways Molecular Biology 1 works
  7. 7 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
  8. 8 Antimicrobial Resistance in Staphylococcus Infectious Diseases 0 works
  9. 9 Cancer Mechanisms and Therapy Pathology and Forensic Medicine 0 works
  10. 10 Immunotherapy and Immune Responses Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.3%not open48.7%

World: 28% of research is openly available.

with international co-authors13.3%domestic only86.7%

World: 19% is written across borders.

How has Melinta Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 59% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in New Haven

All research institutions in New Haven

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.